Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00392691
What this trial is testing

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Lymphoma
Swiss Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT01676961
What this trial is testing

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+2 more
NYU Langone Health 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT05014646
What this trial is testing

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT02206503
What this trial is testing

Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07648459
What this trial is testing

CM336-SOC for Dynamically High-Risk Multiple Myeloma Study

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 46
Not applicableActive Not RecruitingNCT06146920
What this trial is testing

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Who this might be right for
MelanomaNon-small Cell Lung Cancer
Massachusetts General Hospital 39
Post-approval studies (Phase 4)UnknownNCT05382013
What this trial is testing

Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment

Who this might be right for
ThrombocytopeniaHepatitis B, ChronicAcute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Large-scale testing (Phase 3)Looking for participantsNCT06615479
What this trial is testing

Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Who this might be right for
Relapsed or Refractory Multiple Myeloma (RRMM)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 440
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00777998
What this trial is testing

Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 221
Not applicableStudy completedNCT04764747
What this trial is testing

Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19

Who this might be right for
Covid19
Kufa University 400
Not applicableLooking for participantsNCT05224726
What this trial is testing

Platelet Rich Plasma for Uterine Scar

Who this might be right for
Cesarean Section ComplicationsUterine BleedingPelvic Pain+1 more
The University of Texas Health Science Center, Houston 40
Not applicableLooking for participantsNCT06039735
What this trial is testing

Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma

Who this might be right for
Multiple Myeloma
Qilu Hospital of Shandong University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05827016
What this trial is testing

Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 1,230
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06169215
What this trial is testing

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 58
Post-approval studies (Phase 4)Study completedNCT01179893
What this trial is testing

Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis

Who this might be right for
Myasthenia Gravid
University Health Network, Toronto 87
Not applicableUnknownNCT04721236
What this trial is testing

Early Use of Hyperimmune Plasma in COVID-19

Who this might be right for
Covid19
Catherine Klersy 260
Testing effectiveness (Phase 2)Study completedNCT01246063
What this trial is testing

Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 40
Next Page